Body & Mind

Big Pharma’s Lurid Tactics Under Fire In China – And In The US

At first, it was just multinational drugmaker GlaxoSmithKline that allegedly paid bribes in China, including “sexual bribes,” to “government officials, medical associations, hospitals and doctors,” by using travel agencies as conduit. For a total of $489 million. Now more big drugmakers are on the hot seat for the same crimes in China – and in the US.

Is The “Self-Promotion-And-Envy Spiral” Taking Down Facebook?

Facebook isn’t over the hill, exactly. Last October, it announced that 1 billion people a month used it, in a world of 7 billion. Leaping from one milestone to the next. But in key markets, such as the US where it derives most of its revenues, it is plateauing, and a shudder-inducing D-word has snuck into polite conversation: declining. Now we have a new reason.

Medicare, The Corporate Welfare Program

Congress excels at enriching corporate welfare programs—in this case, Medicare. Ironically, it happened while Congress is struggling to rein in Medicare’s gargantuan deficits with belt-tightening measures that would hit people who paid into the system throughout their working years. This time, the prime beneficiary was Big Pharma, particularly one company….

Paradigm Shift For The Healthcare Expense Monster

A sadly familiar theme in the US—the growing ranks of the working poor—was fleshed out today. But the report did something else: it added graphic details to the conundrum of US healthcare spending: while it ballooned to $2.7 trillion, 17.9% of GDP, or $8,680 per capita, households have lowered their share. So have businesses. What gives?